| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |